SCHEMBL5332980

SCHEMBL5332980

COc1ccc(O)c(NC(C)=O)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MAPT P10636 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
ALDH1A1 P00352 4/20 0.45
TSHR P16473 1/20 0.45
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
IDO1 P14902 1/20 0.42
MAOB P27338 2/20 0.42
MAOA P21397 1/20 0.42
KCNMA1 Q12791 3/20 0.40
ATM Q13315 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20612886 0.81 ALDH1A1 (0.44) KDM4EMAPTALDH1A1TSHRCYP1A2
SCHEMBL19301986 0.78 ALDH1A1 (0.41) KDM4EHSD17B10MAPTSAE1UBA2
SCHEMBL3208371 0.77 MAPT (0.52) KDM4EHSD17B10MAPTSAE1UBA2
SCHEMBL27782173 0.77 MAPT (0.52) KDM4EMAPTALDH1A1TSHRCYP1A2
SCHEMBL9826464 0.75 ALDH1A1 (0.46) KDM4EMAPTALDH1A1TSHRCYP1A2
SCHEMBL5409015 0.75 ALDH1A1 (0.59) KDM4EHSD17B10MAPTALDH1A1TSHR
Acetic Acid SCHEMBL5042428 0.74 HTT (0.47) KDM4EMAPTALDH1A1TSHRSLC22A6
SCHEMBL14795733 0.73 CYP3A4 (0.53) MAPTTSHRSLC22A6SLC22A8MEN1
SCHEMBL10638316 0.72 ALDH1A1 (0.46) KDM4EHSD17B10MAPTALDH1A1TSHR
SCHEMBL7500143 0.72 KDM4E (0.53) KDM4EHSD17B10MAPTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed